In conclusion, our meta-analysis confirmed that elevations in CRP, NLR, and GPS/mGPS are associated with poorer survival outcome in GC patients, with a higher GPS/mGPS having a greater negative effect on overall survival. The gene discussed is CRP; the disease is gastric cancer.